These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18166880)

  • 1. Colorectal cancer screening program: cost effectiveness of systematic recall letters.
    Tifratene K; Eisinger F; Rinaldi Y; Didelot R; Seitz JF
    Gastroenterol Clin Biol; 2007 Nov; 31(11):929-33. PubMed ID: 18166880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colorectal cancer screening program : Test completion rate and follow-up results after selective mailing of the test kit, based on likelihood of participation].
    Koïvogui A; Vincelet C; Ait-Hadad H; Pellissier H; Valibay S; Kaufmanis A; Benamouzig R
    Rev Epidemiol Sante Publique; 2021 Oct; 69(5):265-276. PubMed ID: 34344563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.
    Stoffel S; Benito L; Milà N; Travier N; Binefa G; Vidal C; Espinosa J; Moreno V; Garcia M
    Prev Med; 2019 Feb; 119():58-62. PubMed ID: 30594532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France.
    Piette C; Durand G; Bretagne JF; Faivre J
    Dig Liver Dis; 2017 Mar; 49(3):308-311. PubMed ID: 27810401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of stopping sending colorectal cancer screening test kits by regular mail.
    Koïvogui A; Ecochard R; Le Mab G; Benamouzig R
    Public Health; 2019 Aug; 173():33-41. PubMed ID: 31252152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
    Coronado GD; Green BB; West II; Schwartz MR; Coury JK; Vollmer WM; Shapiro JA; Petrik AF; Baldwin LM
    Cancer; 2020 Feb; 126(3):540-548. PubMed ID: 31658375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost of a mass screening program for colorectal cancer using the occult blood test].
    Arveux P; Faivre J; Bedenne L; Durand G; Milan C; Milan C
    Gastroenterol Clin Biol; 1992; 16(6-7):547-51. PubMed ID: 1526416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effective analysis of recall methods for cervical cancer screening in Selangor--results from a prospective randomized controlled trial.
    Rashid RM; Ramli S; John J; Dahlui M
    Asian Pac J Cancer Prev; 2014; 15(13):5143-7. PubMed ID: 25040965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program in a Latino-Based Community Health Center.
    Thompson JH; Davis MM; Michaels L; Rivelli JS; Castillo ML; Younger BM; Castro M; Reich SL; Coronado GD
    J Am Board Fam Med; 2019; 32(3):307-317. PubMed ID: 31068395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
    Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study.
    Coronado GD; Thompson JH; Petrik AF; Nyongesa DB; Leo MC; Castillo M; Younger B; Escaron A; Chen A
    J Am Board Fam Med; 2019; 32(3):318-328. PubMed ID: 31068396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
    Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
    Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
    Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
    Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of an advance notification letter to increase colorectal cancer screening.
    Cronin P; Goodall S; Lockett T; O'Keefe CM; Norman R; Church J
    Int J Technol Assess Health Care; 2013 Jul; 29(3):261-8. PubMed ID: 23778152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.